👨‍⚕️ Docteur en médecine, avec félicitations du jury et médaille d'argent de thèse.
❓ Sujet : prise en charge de la plaque carotidienne en prévention primaire.
➡️ La suite : doctorat de sciences sur l'IA en médecine cardiovasculaire au LIMICS et Zoī.
Let's go!
#MedSky #VascularMedicine #CardioAI

Machine learning models for predicting PCI outcomes had slightly higher accuracy than logistic regression, & the differences weren’t statistically significant. High risk of bias and interpretability issues remain key barriers #CardioAI #PCI #AIinMedicine #cardiology
link.springer.com/article/10.1...

Registration is now open the CardioAI SCCT-endorsed Level II A practical, case-based learning in coronary CTA, plaque assessment, AI-enabled CT analysis, structural cases, Available both in person in Dubai and also fully virtual

.
Link below⬇️⬇️

cardioai.health/register/lev...

LataMed AI (OTC: LMED) will present at Artificial Intelligence & Health Markets 2026 in Caracas on Aug 13-14, showcasing CardioAI, PulmoAI, and NeuroAI platforms for Latin American healthcare professionals and students. #HealthcareAI #DigitalHealth

LataMed AI Corp. (OTC: LMEDD) has completed its 5-for-1 forward stock split effective July 15, 2026. The company continues advancing its CardioAI, PulmoAI, and NeuroAI platforms for emerging markets. #DigitalHealth #AIHealthcare

LataMed AI (OTC: LMED) plans to attend World Health Expo 2027 in Dubai to explore global healthcare expansion, while a 5-for-1 stock split takes effect July 15, 2026. The company advances its CardioAI, PulmoAI, and NeuroAI platforms across emerging markets. #DigitalHealth #Telehealth

LataMed AI Corp. (OTC: LMED) has filed all required documents with FINRA for its 5-for-1 forward stock split, expected effective within one week. Most shareholders need no action. CEO eyes CardioAI, PulmoAI & NeuroAI commercialization next. #DigitalHealth #Telemedicine

Catalyst Crew Technologies launches CardioAI, an AI platform for cardiovascular risk assessment and clinical decision support. The technology targets Latin America's growing digital health needs. #HealthTech #AI

Catalyst Crew Technologies assigns three Venezuelan patents to subsidiary, positioning AI healthcare technologies CardioAI, PulmoAI, and NeuroAI for regional expansion and global IP strategy. #HealthTech #AI

#CardioAI #CardioX #Cardiotwitter #DigitalHealth

#Amyloidosis #CardioAI #AIinMedicine #ECG #Echo #DigitalHealth #CardioX

Full manuscript: jamanetwork.com/journals/jam...

Announcing our final Keynote Lecture at Krakow Conference on Computational Medicine 2025:
Daniel Taylor (University of Sheffield) on 🩺 “Computing coronary physiology: Conception, Optimisation and Clinical Application.”

#KrakowConference #ComputationalMedicine #MedicalAI #CardioAI

CardioAI: An Explainable Machine Learning System for Cardiovascular Risk Prediction and Patient Retention in Nigerian Healthcare Settings https://www.medrxiv.org/content/10.64898/2026.03.29.26349642v1